Dr Örn Almarsson gives an invited lecture to TBSI

Örn Almarsson, Head of Formulation of Moderna Therapeutics in Cambridge, Massachusetts, gave a lecture about his work titled “Messenger RNA: A Novel Therapeutic Approach”, today. Moderna Therapeutics have demonstrated the possibilities offered by mRNA-based treatments, establishing partnerships with Merck, receiving awards for their research achievements and raising over $1.1 billion in equity financing.

Örn was invited to speak to TBSI by Thorri, of whom he is a longtime friend. It was a pleasure to have him talk about his work and provide a unique insight into the world of cutting-edge industry research.

 

Advertisements